| First Author | Petrova SC | Year | 2020 |
| Journal | Oncotarget | Volume | 11 |
| Issue | 43 | Pages | 3832-3848 |
| PubMed ID | 33196707 | Mgi Jnum | J:310572 |
| Mgi Id | MGI:6763489 | Doi | 10.18632/oncotarget.27783 |
| Citation | Petrova SC, et al. (2020) Regulation of breast cancer oncogenesis by the cell of origin's differentiation state. Oncotarget 11(43):3832-3848 |
| abstractText | Human breast cancer which affects 1/8 women is rare at a cellular level. Even in the setting of germline BRCA1/BRCA2, which is present in all breast cells, solitary cancers or cancers arising at only several foci occur. The overwhelming majority of breast cells (10(9)-10(12) cells) resist transformation. Our hypothesis to explain this rareness of transformation is that mammary oncogenesis is regulated by the cell of origin's critical window of differentiation so that target cells outside of this window cannot transform. Our novel hypothesis differs from both the multi-hit theory of carcinogenesis and the stem/progenitor cell compartmental theory of tumorigenesis and utilizes two well established murine transgenic models of breast oncogenesis, the FVB/N-Tg (MMTV-PyVT)634Mul/J and the FVB-Tg (MMTV-ErbB2) NK1Mul/J. Tail vein fibroblasts from each of these transgenics were used to generate iPSCs. When select clones were injected into cleared mammary fat pads, but not into non-orthotopic sites of background mice, they exhibited mammary ontogenesis and oncogenesis with the expression of their respective transgenes. iPSC clones, when differentiated along different non-mammary lineages in vitro, were also not able to exhibit either mammary ontogenesis or oncogenesis in vivo. Therefore, in vitro and in vivo regulation of differentiation is an important determinant of breast cancer oncogenesis. |
